Edition:
United States

Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

116.25USD
22 Jul 2016
Change (% chg)

$0.24 (+0.21%)
Prev Close
$116.01
Open
$116.07
Day's High
$116.47
Day's Low
$115.07
Volume
435,028
Avg. Vol
644,947
52-wk High
$119.90
52-wk Low
$67.81

Select another date:

Tue, May 3 2016

BRIEF-Abiomed reports Q4 GAAP earnings per share $0.24

* Abiomed announces Q4 FY 2016 revenue of $94.0 million, up 39% over prior year

BRIEF-Abiomed posts Q4 earnings per share $0.24

* Abiomed announces Q4 FY 2016 revenue of $94.0 million, up 39 pct over prior year

FDA approves Abiomed's device to treat cardiac shocks

The U.S Food and Drug Administration approved Abiomed Inc's heart pump to treat patients who suffer cardiac shock after heart attack or heart surgery, sending its shares up about 4 percent in extended trading.

FDA approves Abiomed's device to treat cardiac shocks

April 7 The U.S Food and Drug Administration approved Abiomed Inc's heart pump to treat patients who suffer cardiac shock after heart attack or heart surgery, sending its shares up about 4 percent in extended trading.

BRIEF-Abiomed Impella therapy receives FDA approval

* Abiomed impella therapy receives fda approval for cardiogenic shock after heart attack or heart surgery

BRIEF-Abiomed does not anticipate FDA advisory panel prior to PMA approval

* Co, FDA agreed on indication for use for pre-market approval ('PMA') for Impella 2.5, Impella CP, Impella 5.0 and Impella LD devices

Select another date: